Suboxone lawsuits are blooming in the U.S, claiming that the medication used to treat opioid addiction causes dental problems in the patients. Buprenorphine and naloxone are the two main ingredients of suboxone, a Schedule III prescription medication. Brand-name Suboxone products are produced and distributed by the American company Indivior, which is headquartered in Richmond, Virginia. The drug is injected sublingually (under the tongue) or buccally (inside the cheek). This technique prevents misuse by guaranteeing that naloxone won't negate the effects of buprenorphine unless the drug is injected.
Behavioral therapy and counseling are often used in medication-assisted treatment (MAT) for opioid addiction, along with Sublingual Film® (CIII). MAT programs offer a "whole-patient" approach that lowers the risk of overdose, increases the rate of sobriety, and assists people in leading more stable lives.
According to the current Suboxone injury lawsuits, Indivior failed to provide a suitable warning about the drug's potential to cause dental problems. When suboxone users began to experience oral and dental problems such as cavities, infections, tooth decay, and tooth loss, the number of tooth decay lawsuits involving the drug began to rise.
David Sorensen filed a Suboxone product liability lawsuit in the Northern District of Ohio U.S. District Court on September 25, 2023. In the Suboxone tooth decay lawsuit, Beckitt Benckiser, Aquestive Therapeutics, Indivior, and MonoSol Rx were named as defendants. The plaintiff in the Suboxone case, Sorenson, stated he needed extensive and costly dental care because he had irreversible tooth decay.
Another Geauga County plaintiff filed a second Suboxone tooth decay lawsuit on October 16, 2023. The lawsuit claims that Suboxone was prescribed to the plaintiff in order to treat his opioid addiction. The plaintiff experienced severe tooth decay after 16 months of use, necessitating multiple permanent tooth extractions.
14 new Suboxone lawsuits against Indivior were pending in federal courts as of November 3, 2023. Suboxone tooth decay lawsuits have not yet been combined into an MDL or class action lawsuit.
However, given the prevalence of opioid addiction cases and the drugs used to combat it, Suboxone lawsuit attorneys predict that by 2024, Suboxone lawsuits will rank among the largest product liability lawsuits filed in the US.
Medical record review services USA can offer vital information regarding the efficacy of suboxone in treating opioid addiction as well as any negative side effects the claimants may have encountered. When it comes to Suboxone lawsuits where the drug's effectiveness or safety are contested, medical records retrieval companies for lawyers are crucial support.
Examining medical records can show whether Suboxone was prescribed in compliance with recognized medical norms and protocols. Medical records can be important evidence in cases where improper prescribing is alleged. Medical records review service is also an important source of evidence when it comes to cases where the claimant states that Suboxone caused dependency or severe withdrawal symptoms. These records detail the claimant's experience using the drug. Reports from sorting index for medical records can also be very helpful in confirming the plaintiffs' allegations in court.
